Head to head
Crane vs GE Vernova
Side-by-side on the measures that matter, with a plain-English read. Full detail: CR · GEV
CR
Crane
202.13-3.46%
1-year price shape — +15% over the period
Quant Rating C · 57/100
vs
GEV
GE Vernova
699.33-7.53%
1-year price shape — +26% over the period
Quant Rating D · 62/100
1-year performance, rebased to 100
GE Vernova edges it on the scoreable measures. GE Vernova has the highest Quant Rating (62); GE Vernova has done best over the past year (+26%); GE Vernova trades cheapest on trailing earnings.
| CR | GEV | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 202.13 | 699.33 |
| Change today | -3.46% | -7.53% |
| 1-year return | +15.3% | +25.6% |
| Market cap | $11.69B | $185.10B |
| 52-week range | 159.16 – 230.22 | 551.90 – 1,195.24 |
| Valuation | ||
| P/E (TTM) | 34.73 | 18.36 |
| P/E percentile, own 5-yr range | 79th | 13th |
| P/B | 5.16 | 16.26 |
| Dividend yield | 0.49% | 0.25% |
| Profitability & growth | ||
| EPS (TTM) | 6.26 | 17.69 |
| Net profit (TTM) | $362.04M | $4.68B |
| Revenue (TTM) | $2.76B | $44.04B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +28.1% | +26.8% |
| Gross margin | 41.5% | 21.7% |
| Operating margin | 17.7% | 6.4% |
| Net margin | 12.4% | 23.5% |
| Free cash flow (TTM) | $379.80M | $17.12B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 80.6% | 78.9% |
| Insider activity (12mo) | 31 buy / 19 sell | 35 buy / 15 sell |
| Short interest (% of float) | 2.2% | 2.8% |
| Analyst consensus | 100% buy (5) | 78% buy / 17% hold / 6% sell (18) |
| Analyst price target | $250 (+24%) | $1,137 (+63%) |
| StockVane view | ||
| StockVane Quant Rating | C (57) | D (62) |
| Company | ||
| Employees | 7,100 | 78,000 |
| Founded | 1855 | 2021 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.